Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-18

Clinical Trial Update: Treatment of Chronic Stroke With AMES + EMG Biofeedback [NA]

View source ↗

Summary

Clinical trial of AMES technology with EMG biofeedback for chronic stroke has completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMES Technology AMES + EMG Biofeedback (AMES Technology AMES + EMG Biofeedback)

Snippet

Sponsor: AMES Technology | Conditions: Stroke, Plegia | NA | Status: COMPLETED | Results posted: 2019-11-18